Balkrishna Industries Ltd. outlines growth roadmap and FY27 highlights
Balkrishna Industries Ltd. (BKT) has presented its growth roadmap, detailing ambitious revenue targets by 2030 and highlighting key…
Augmont Enterprises Limited reports Q2 FY27 results and approves ESOP plan
Augmont Enterprises Limited has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended…
Aurobindo Pharma declares 700% interim dividend of Rs 7 per share
Aurobindo Pharma Limited announced a significant development post its Board of Directors meeting held on November 4, 2026. The company has…
Reliance Industries’ Senior Unsecured Notes reaffirmed ‘A-‘ rating with stable outlook
S&P Global Ratings has reaffirmed the credit rating of “A-” with a “Stable” outlook for Reliance Industries Limited’s Senior…
Krishna Institute of Medical Sciences approves merger of subsidiary
Krishna Institute of Medical Sciences Limited has approved the amalgamation of its wholly-owned subsidiary, KIMS Hospitals Private Limited,…
Aurobindo Pharma re-appoints independent director for five-year term
Aurobindo Pharma Limited’s Board of Directors has approved the re-appointment of Mr. Mangalam Ramasubramanian Kumar as a Non-executive…
Aurobindo Pharma reorganizes Russian subsidiary ownership with INR 29 crore cash consideration
Aurobindo Pharma Limited has announced the transfer of ownership of its Russian subsidiary, Auro Pharma LLC. The move involves transferring…
Entero Healthcare approves Q2 FY27 financial results and grants employee stock options
Entero Healthcare Solutions Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended…
Aurobindo Pharma approves merger of two wholly owned subsidiaries
Aurobindo Pharma Limited has announced the approval of its board for a Scheme of Amalgamation involving two of its wholly owned subsidiaries:…
Entero Healthcare reports Q2 FY27 results and approves stock options
Entero Healthcare Solutions Limited has announced the outcome of its Board Meeting held on November 4, 2026. The company approved its…